Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches

Aug.26.2025
Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Group, Ltd. files federal lawsuit against Altria Group for alleged theft of trade secrets in packaging "On!" nicotine pouches.

Key Points: 

 

Plaintiff: UK-based Gumipod Group, Ltd.

Defendants: Altria Group, Inc. and three subsidiaries — Altria Client Services LLC, Helix Innovations LLC (believed to be the owner of the “On!” brand), and Altria Group Distribution Company.

Dispute Origin: After the signing of a confidentiality agreement in 2018, Gumipod provided samples and specifications; Altria announced the collaboration was on hold, but in 2019 launched “On!” nicotine pouches.

Core Allegations: Violations of the Defend Trade Secrets Act (DTSA), violations of the Virginia Uniform Trade Secrets Act (VUTSA), breach of contract, unjust enrichment, and business conspiracy.

Claims: Cease infringement, compensate for losses and punitive damages, pay legal fees, and obtain a permanent injunction.

 


 

On August 22, 2025, according to documents released by the Eastern District Federal Court of Texas in the United States, Gumipod Group, Ltd., based in London, filed a federal lawsuit against tobacco company Altria Group (Altria Group, Inc.) and several of its subsidiaries. The lawsuit accuses Altria of misappropriating its trade secrets for use in the packaging of its popular “On!” brand nicotine pouch products.

 

The defendants named in the complaint include Altria Group itself, along with its three subsidiaries: Altria Client Services LLC, Helix Innovations LLC (alleged to own the “On!” brand), and Altria Group Distribution Company.

 

According to the filing, Gumipod was founded by Duval Middleton in 2011 and developed an innovative “plastic capsule-style gum container” with a built-in recycling bin, allowing consumers to conveniently dispose of chewed gum.

 

In August 2018, Emily Ornelas, then a procurement analyst for Altria, contacted Middleton through Gumipod’s website. Shortly afterward, Kwazna Downs, then Altria’s purchasing manager, reached out via Facebook, clarifying that Altria’s interest was in applying the technology to “nicotine products derived from oral tobacco,” rather than gum.

 

To advance discussions, the parties signed a Mutual Confidentiality Agreement (MCA). A key clause stipulated that the obligation to protect trade secrets would remain in effect “as long as trade secret protection is still available.” Following this, Gumipod provided Altria with 10 product samples and detailed production specifications. However, in October 2018, Altria abruptly notified Gumipod that the project was “on hold.”

 

Less than a year later, in June 2019, Altria publicly acquired and relaunched the “On!” nicotine pouch brand. Gumipod alleges that it did not discover the misappropriation until August 24, 2022, when former Gumipod employee Julian Hogan forwarded Altria’s internal marketing documents related to “On!” to Middleton. Gumipod claims that these documents demonstrated the use of its proprietary packaging technology in the design and marketing of On! products.

 

From a legal perspective, Gumipod has filed five causes of action: violation of the Defend Trade Secrets Act (DTSA), violation of the Virginia Uniform Trade Secrets Act (VUTSA), breach of contract, unjust enrichment, and violation of the Virginia Business Conspiracy Act.

 

The plaintiff is requesting a jury trial and is seeking court orders requiring Altria and its subsidiaries to:

 

Immediately cease the use and sale of products alleged to infringe Gumipod’s intellectual property;

Compensate Gumipod for actual losses and punitive damages (amount to be determined at trial);

Pay legal fees and court costs;

Grant a permanent injunction prohibiting further use of Gumipod’s trade secrets and technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
The Philippine Department of Health said it is pushing for a total ban on vape products. If a full ban is not feasible, DOH officer-in-charge Director Dr. Dominic Maddumba said vape products should at least be limited to plain tobacco flavors to reduce their appeal to minors.
May.06 by 2FIRSTS.ai
Türkiye Records 4,163 E-Cigarette Smuggling Raids Over Five Years, With Seizures Worth TRY 1.84 Billion
Türkiye Records 4,163 E-Cigarette Smuggling Raids Over Five Years, With Seizures Worth TRY 1.84 Billion
Turkish Trade Minister Ömer Bolat disclosed enforcement figures on e-cigarette smuggling in response to a written parliamentary question. Over the past five years, Türkiye recorded 4,163 raids targeting e-cigarette smuggling, preventing illegal e-cigarettes, liquids and components worth TRY 1.84 billion, or about USD 40.68 million based on an exchange rate of USD 1 = TRY 45.2339, from reaching the market.
May.07 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Thai Customs Plans Shift to Per-Unit Fines for Vapes at THB 100 Per Item
Thai Customs Plans Shift to Per-Unit Fines for Vapes at THB 100 Per Item
Thai Customs said on March 18 that it had seized more than 27.3 million foreign cigarettes and 205,445 vape products and related devices in mid-February, with a total value of more than THB 169 million.
Mar.19 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Cambodia Moves to Draft New Tobacco Control Strategy Targeting Illicit Products and E-Cigarette Spread
Cambodia Moves to Draft New Tobacco Control Strategy Targeting Illicit Products and E-Cigarette Spread
Cambodian Health Minister Cheang Ra has called for the development of a tobacco control strategy for 2027–2031, with the goal of reducing tobacco use by 30% by 2030. The directive was issued during a Tobacco Product Control Committee meeting in Phnom Penh. Priority areas include reducing tobacco use, protecting the public from secondhand smoke, tackling illegal and counterfeit tobacco products, and preventing the spread of e-cigarettes.
Apr.29 by 2FIRSTS.ai